Vantage Investment Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Vantage Investment Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$10K	Hold	100	–	–	﹤0.01%	539
2018 Q2	$12K	Hold	100	–	–	﹤0.01%	513
2018 Q1	$10K	Hold	100	–	–	﹤0.01%	565
2017 Q4	$10K	Hold	100	–	–	﹤0.01%	590
2017 Q3	$11K	Hold	100	–	–	﹤0.01%	550
2017 Q2	$11K	Hold	100	–	–	﹤0.01%	538
2017 Q1	$12K	Hold	100	–	–	﹤0.01%	504
2016 Q4	$11K	Hold	100	–	–	﹤0.01%	498
2016 Q3	$11K	Hold	100	–	–	﹤0.01%	483
2016 Q2	$15K	Buy	+100	New	+$14.2K	0.01%	464

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Vantage Investment Advisors's TARO Position: Q3 2018 in Review

Vantage Investment Advisors held its Taro Pharmaceutical Industries Ltd. (TARO) position steady in Q3 2018 at 100 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Vantage Investment Advisors first reported a position in TARO in Q2 2016 and has held it in 10 quarters since. The position peaked at $15K in Q2 2016. 114 funds tracked by Wall St. Rank hold TARO as of Q3 2018.

Vantage Investment Advisors held 100 shares of Taro Pharmaceutical Industries Ltd. worth $10K as of Q3 2018.
Vantage Investment Advisors left its Taro Pharmaceutical Industries Ltd. share count unchanged in Q3 2018.
Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Vantage Investment Advisors's portfolio in Q3 2018, its #539 holding.
Vantage Investment Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2016 and has held it in 10 quarters since.
Vantage Investment Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $15K in Q2 2016.
114 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.